$94.61 +0.04 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Juno Therapeutics IPO Hot As Cancer Curers In Demand

    IBD | Dec. 19, 2014 | 18:32PM EST
  2. United Therapeutics Lung Drug Keeps Going And Going

    IBD | Dec. 19, 2014 | 17:20PM EST
  3. Morning Market Movers

    Benzinga | Dec. 16, 2014 | 09:42AM EST
  4. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 16, 2014 | 08:05AM EST
  5. US Stock Futures Edge Lower; Crude Oil Drops

    Benzinga | Dec. 16, 2014 | 07:03AM EST
  6. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD | Dec. 12, 2014 | 10:38AM EST
  7. Novartis Reports Results of Trial Evaluating Use of Afinitor

    Benzinga | Dec. 12, 2014 | 08:34AM EST
  8. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD | Dec. 2, 2014 | 17:14PM EST
  9. Morgan Stanley Pair Trade On Novartis And AstraZeneca

    Benzinga | Dec. 2, 2014 | 14:01PM EST
  10. Novartis' MS drug fails trial

    IBD | Dec. 1, 2014 | 18:35PM EST
  11. Novartis' Gilenya Fails To Treat Progressive MS

    IBD | Dec. 1, 2014 | 11:29AM EST
  12. 5 Stock-Moving Medtech Events This December

    IBD | Nov. 28, 2014 | 14:18PM EST
  13. US Stock Futures Edge Higher Ahead Of GDP, Housing Data

    Benzinga | Nov. 25, 2014 | 07:35AM EST
  14. Can Partnering To Fight Hepatitis C Pay At Entanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  15. Can Partnering To Fight Hepatitis C Pay At Enanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  16. Will IPOs WhiteWave, Enanta Surpass Buy Points?

    IBD | Nov. 17, 2014 | 18:27PM EST
  17. Novartis Int'l Reports Nine New Analyses Show Co.'s LCZ696 Could Avert Course of Heart Failure for Patients

    Benzinga | Nov. 17, 2014 | 16:47PM EST
  18. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  19. Kahn Brothers' Third Quarter Numbers

    GuruFocus | Nov. 7, 2014 | 17:43PM EST
  20. Veeva Systems Flies High On Cloud For Life Sciences

    IBD | Oct. 30, 2014 | 17:31PM EST
  21. Novartis

    IBD | Oct. 28, 2014 | 18:46PM EST
  22. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  23. Novartis Posts Higher Q3 Profit

    Benzinga | Oct. 28, 2014 | 06:17AM EST
  24. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  25. Can Valeant's Strong Q3 Entice Allergan?

    IBD | Oct. 20, 2014 | 18:47PM EST
  26. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  27. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Oct. 10, 2014 | 07:20AM EST
  28. New MS Drugs Offer Promise

    IBD | Sep. 26, 2014 | 18:56PM EST
  29. Multiple Sclerosis Drugs Could Transform Market Again

    IBD | Sep. 26, 2014 | 18:07PM EST
  30. International Securities For A Diversified Income Portfolio

    GuruFocus | Sep. 23, 2014 | 13:36PM EST
  31. Could European Funds Offer An Opportunity Now?

    Benzinga | Sep. 23, 2014 | 10:04AM EST
  32. IPO Stock Watch: Biotech ProQR Rises In IPO Debut

    IBD | Sep. 18, 2014 | 12:54PM EST
  33. 3 Companies Investing In Stem Cell Research

    Benzinga | Sep. 14, 2014 | 16:34PM EST
  34. Good news for Receptos drug

    IBD | Sep. 10, 2014 | 18:53PM EST
  35. ReceptosMS Drug Yields More Good Data; Stock Jumps

    IBD | Sep. 10, 2014 | 11:58AM EST
  36. ECB Decision Boosts ETFs

    Benzinga | Sep. 4, 2014 | 16:02PM EST
  37. Novartis Drug Is Heartening

    IBD | Sep. 2, 2014 | 18:39PM EST
  38. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD | Sep. 2, 2014 | 18:04PM EST
  39. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD | Sep. 2, 2014 | 11:19AM EST
  40. Benzinga's Volume Movers

    Benzinga | Sep. 2, 2014 | 10:25AM EST
  41. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  42. Novartis: Ten Years of Solid ROE

    GuruFocus | Jul. 31, 2014 | 19:06PM EST
  43. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD | Jul. 23, 2014 | 18:17PM EST
  44. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD | Jul. 23, 2014 | 11:56AM EST
  45. 5 New Medical Technologies For Diabetics

    Benzinga | Jul. 18, 2014 | 13:10PM EST
  46. Novartis Joins Google To Develop Contacts For Diabetics

    Benzinga | Jul. 18, 2014 | 09:59AM EST
  47. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West At An All Time High

    Benzinga | Jul. 18, 2014 | 07:16AM EST
  48. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga | Jul. 17, 2014 | 16:50PM EST
  49. Earnings Scheduled For July 17, 2014

    Benzinga | Jul. 17, 2014 | 05:08AM EST
  50. Google's X division

    IBD | Jul. 15, 2014 | 19:15PM EST
Trading Center